CSL Behring Expert Portal is a global web portal designed for healthcare professionals (HCPs) outside the US who are interested in serious and life-threatening conditions. Register and login to access the information on this webpage and to receive updates when new content becomes available for your country. The information provided on this website is for informational purposes only and should not replace professional advice from a healthcare provider in your area. Product labels may vary from country to country. Please ensure to follow the applicable label for your country.

Disclaimer: Due to compliance regulations, not all content of this webpage is intended for UK healthcare practitioners. If you would like to access UK specific materials on this site, please reach out to your local CSL Behring medical representative (medinfo@cslbehring.com) for assistance.

Disclaimer

CSL EXPERT HIVE

Congress symposia

Featured Content

EAHAD 2025: First EU real-world gene therapy experiences in haemophilia B
Haematology

Symposia replays

EAHAD 2025: First EU real-world gene therapy experiences in haemophilia B

Our EAHAD 2025 symposium “First EU real-world gene therapy experiences in haemophilia B: Insights on getting your clinic ready” shared insights and experiences from the real‑world impleme...

Read More
Living the gene therapy treatment journey
Haematology

Symposia replays

Living the gene therapy treatment journey

This symposium presented at the 36th Congress of the World Hemophilia Federation invited a multidisciplinary faculty of patients, a nurse and a haematologist to discuss the gene therapy j...

Read More
Building momentum to raise the standard of care in bleeding disorders
Haematology

Symposia replays

Building momentum to raise the standard of care in bleeding disorders

Catch-up on this educational symposium discussing ways to raise the standard of care for people living with bleeding disorders.

Read More
Living the gene therapy treatment journey

Symposia replays

Living the gene therapy treatment journey

This symposium presented at the 36th Congress of the World Hemophilia Federation invited a multidisciplinary faculty of patients, a nurse and a haematologist to discuss the gene therapy journey for ha...

Haemophilia as a blueprint for gene therapy: Exploring the impact on patients' lives and patient care

Symposia replays

Haemophilia as a blueprint for gene therapy

Co-chaired by Ingrid Pabinger and Wolfgang Miesbach, the EHA 2022 symposium highlighted the current gene therapy landscape in bleeding disorders and the status of gene therapies in clinical trials for...

Gene Therapy: A paradigm shift in haemophilia

Symposia replays

Gene Therapy: A paradigm shift in haemophilia

The EAHAD 2022 symposium highlighted the current haemophilia treatment landscape and what the future holds for haemophilia care, including managing change and shifting mindsets for a new treatment par...

You are in the Medical area, which contains scientific updates and medical insights.

Looking for information about our products?

Switch to the PRO-X area for promotional information about our authorized products in your country to support your treatment strategy.

GO TO THE PRO-X AREA